Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07123896

Arrhythmia Cohort Study

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Arrhythmia Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients hospitalized for any type of arrhythmia

Exclusion criteria

  • Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.

Treatment and study plan

Normal treatment with catheter ablation or medicine

Device

Routine clinical care with catheter ablation and/or medicine; real-world clinical cases

Drug treatment

Drug

Routine clinical care with medicine; real-world clinical cases

Primary outcomes

  1. Arrhythmia recurrence

    Time frame: 1 year

    Recurrence of the arrhythmia after treatment

  2. All-cause death

    Time frame: 1 year

    Death due to any reason

Secondary outcomes

  1. Arrhythmia recurrence

    Time frame: 5 year

    Recurrence of the arrhythmia after treatment

  2. All-cause death

    Time frame: 5 year

    Death due to any reason

  3. Cardiovascular death

    Time frame: 1 year

    Death due to cardiovascular disease

  4. Cardiovascular death

    Time frame: 5 year

    Death due to cardiovascular disease

  5. Heart failure

    Time frame: 1 year

    Heart failure due to cardiovascular disease

  6. Heart failure

    Time frame: 5 year

    Heart failure due to cardiovascular disease

  7. Cardiovascular hospitalization

    Time frame: 1 year

    Hospitalization due to cardiovascular disease

  8. Cardiovascular hospitalization

    Time frame: 5 year

    Hospitalization due to cardiovascular disease

Sponsors and collaborators

Lead sponsor

Beijing Anzhen Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2030
Study completion
2030
First posted
Aug 14, 2025
Registry last updated
Aug 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.